TrialFrontiers in immunology2023

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.

Armin Gerbitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.